Hydrogel‐Based Slow Release of a Receptor‐Binding Domain Subunit Vaccine Elicits Neutralizing Antibody Responses Against SARS‐CoV‐2

The development of effective vaccines that can be rapidly manufactured and distributed worldwide is necessary to mitigate the devastating health and economic impacts of pandemics like COVID‐19. The receptor‐binding domain (RBD) of the SARS‐CoV‐2 spike protein, which mediates host cell entry of the v...

Descripción completa

Detalles Bibliográficos
Autores principales: Gale, Emily C., Powell, Abigail E., Roth, Gillie A., Meany, Emily L., Yan, Jerry, Ou, Ben S., Grosskopf, Abigail K., Adamska, Julia, Picece, Vittoria C. T. M., d'Aquino, Andrea I., Pulendran, Bali, Kim, Peter S., Appel, Eric A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8646307/
https://www.ncbi.nlm.nih.gov/pubmed/34651342
http://dx.doi.org/10.1002/adma.202104362

Ejemplares similares

Ejemplares similares